In the past, the identification of myocardial fibrosis was only possible through invasive
histologic assessment. Although endomyocardial biopsy remains the gold standard, recent …

Hypertrophic cardiomyopathy (HCM) is one of the most common inheritable
cardiomyopathies. Contemporary management strategies, including the advent of …

Background Quantitative late gadolinium enhancement (LGE) cardiac magnetic resonance
provides important prognostic information for sudden cardiac death (SCD) in hypertrophic …

Abstract Background The 2020 American Heart Association (AHA)/American College of
Cardiology (ACC) guidelines for sudden cardiac death (SCD) risk stratification in …

Introduction: Hypertrophic cardiomyopathy (HCM) is a leading cause of lethal arrhythmias in
the young. Although the arrhythmic substrate has been hypothesised to be amenable to late …

Dilated Cardiomyopathy is conventionally defined by left ventricular dilatation and
dysfunction in the absence of coronary disease. Emerging evidence suggests many patients …

Background To compare the clinical and cardiac magnetic resonance (CMR) imaging
findings of coronavirus disease 2019 (COVID-19) vaccine-associated myocarditis (VAM) …

Purpose The aim of this study is to review the literature concerning myocardial late
gadolinium enhancement (LGE) with cardiac magnetic resonance in patients with Tetralogy …

Abstract Background Systemic sclerosis (SSc) affects the myocardium, thereby resulting in a
poor prognosis. Late gadolinium enhancement (LGE) entropy, derived from routine cardiac …

Background Myocardial fibrosis, expressed as late gadolinium enhancement (LGE) on
cardiac magnetic resonance imaging (CMR), is an important risk factor for malignant cardiac …